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Volume 49, Number 5S Poster Presentations 19SObjective: Thoracic Endograft (TAG) placement has become an ac-
ceptable treatment alternative to open surgical repairs. It has been shown
that risk factors for developing a stroke during TAG are obesity, blood loss
and vascular embolization. Manipulation of the aortic arch during cardiac
catheterization has likewise been identified as a source of cerebral emboliza-
tion. The influences of endograft placement on cerebral embolization and
flow is not well described. As such, our aim is to quantify the number of
microembolic signals (MES,) velocities (VEL), and pulsatility index (PI)
detected by Transcranial Doppler (TCD) during different stages of the
endograft placement and correlate them with landing zones, subclavian
revascularization and number of devices used.
Methods: Twenty (20) patients were monitored with TCD during
endovascular repair of the thoracic aorta. Imaging and medical parameters
were entered into a combined database. We recorded middle cerebral artery
(MCA) velocities, pulsatility index (PI) and embolic count.
Results: TCD monitoring was successful in all patients. The highest
MES counts were generated by the pig tail catheter during the diagnostic
stage (DS) and by device placement during deployment phase (DP). Em-
bolic count to right/left (Rt/Lt) sides were the same overall. In DS an
average of 8.65 MES were seen Rt/Lt, while during DP 45.40 and 42.68
MES were seen respectively for Rt and Lt. Baseline MCA velocities were
similar for Rt and Lt and increased significantly from baseline during balloon
inflation from (Rt. 33.5 to 50.2 p-value 0.02; Lt 32.5 to 47.2 p-value
0.001). Similarly, the pulsatility index increased from 0.95 (Rt) and 1.02
(Lt) to 1.43 (Rt) and 1.38 (Lt) (p-value 0.0005 and 0.0009 respectively for
Rt and Lt). There was no correlation between post-operative stroke TIA,
arch type, landing zone or coverage of the subclavian artery and number of
MES.
Conclusions: The ability of TCD to detect cerebral emboli and alter-
ations in flow patterns is important to reveal which steps of thoracic en-
dografting are most likely to provoke emboli and hymodynamic changes. It
also has a potential to compare endografts and their capacity to generate
emboli.
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Thoracic Endovascular Repair (TEVAR)
Frank R Arko, III, Erin H Murphy, Charles M Davis, Stephen T Smith, J
Gregory Modrall, G Patrick Clagett. University of Texas Southwestern
Medical Center, Dallas, TX
Background:Mortality and complication rates for open thoracic aortic
aneurysm repair have declined but still remain high. Recently with the
introduction of TEVAR morbidity and mortality have improved, but in a
large general population are unknown. The purpose of this study is to
determine the influence of ethnicity and insurance type on procedure
selection and outcome following TEVAR.
Methods: Using the Nationwide Inpatient Sample (NIS) database
ethnicity and insurance type were evaluated against the outcome variables of
mortality and complications associated with thoracic aneurysm repair.
Results: Between 2001-2005, a total of 875 patients undergoing
TEVAR were analyzed with a significantly greater proportion of Caucasians
over African Americans and Hispanics (650, 104, and 49, respectively) with
72 patients categorized as other. The majority of subjects in all races were
male and most of the procedures were elective. The overall mortality was
13.3% (n117) and spinal cord ischemia was 0.8% (n7) with no difference
between ethnicity and insurance type. Significant differences were notable in
all demographic characteristics among races including gender (p0.003),
income (p0.0001), hospital region of surgery (p0.001), hospital bed size
(p0.013), and insurance type (p0.001). Variations in demographic
characteristics were also present in the univariate analysis associated with
insurance classifications with significant differences in gender (p0.001),
surgery type (p0.009), income (p0.003), race p0.0001) and comor-
bidity index (p0.0001). Bivariate analysis by race resulted in few statisti-
cally significant differences except for infection (p0.007) and other com-
plications (p0.003) with African Americans and Hispanics having a higher
incidence respectively. Bivariate comparison by insurance resulted in a
greater number of significant differences including nonroutine discharge
(p0.009), intestinal ischemia (p0.039), and transfusions (p0.003).
Conclusions: There is a significant difference in ethnicity in the repair
of thoracic aneurysms but no difference in mortality among groups. The
incidence of spinal cord ischemia is very low with no difference between
groups. Ethnicity and type of insurance is associated with a higher risk of
complications with TEVAR.
Author Disclosures: F.R. Arko, None; E.H. Murphy, None; C.M.
Davis, None; S.T. Smith, None; J.G. Modrall, None; G.P. Clagett,
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TEVAR in Female Patients: Increased Aortic Coverage is Associated
with a Higher Risk of Spinal Cord Ischemia
Tejas R. Shah, StephenMBauer, Neal S Cayne, ThomasMaldonado, Caron
Rockman. New York University Medical Center, New York, NY
Background: There is a paucity of literature regarding thoracic endo-
vascular aneurysm repair (TEVAR) in women. We report our institutional
experience with TEVAR in women.
Methods: A retrospective chart review was performed. Case planning
was done with CTa. Patients with small access vessels received a 10mm
common iliac artery (CIA) conduit. Patients received a CTa 30-days post-
operatively. Post-operative stroke was diagnosed clinically and by cerebral
imaging. Spinal cord ischemia (SCI) was diagnosed clinically with negative
cerebral imaging.
Results: TEVAR was performed in 51 patients for a variety of aortic
pathologies; of these 29 (56%) were female. The mean age of women was
73.5 years. Mean TAA diameter was larger for women than for men (5.9 cm
vs. 4.7 cm). TEVARwas performedmore often on an urgent basis in women
as compared to men (20.7% vs. 9.5%, p NS). There was a trend towards
pain as the predominant presenting symptom in women as compared tomen
(44.8% vs. 22.7%, p NS). There was a statistically significant difference in
the need for a CIA conduit in women compared to men (48.3% vs. 20.0%,
p0.05). This was not associated with an increase in peripheral ischemic
complications or an increase length of stay (LOS). There were no differences
in endoleak rate, stroke, or post-operative death. Although not statistically
significant, there was a concerning trend towards an increase in paraplegia in
women, 10.3% versus 4.8%. This may be related to the statistically significant
increase in the total length of aortic coverage required in women compared
to men, 18.2 cm versus 15.2 cm (p0.05).
Conclusion: Our data suggests that TEVAR in women is safe and
effective. Women presented more frequently with indications for urgent
intervention. As expected, women require a conduit more often due to
smaller access vessel size, but this does not increase the rate of peripheral
ischemic complications or LOS. The length of aortic coverage is greater in
women than in men, and this may be related to their being treated for larger
aneurysms and more advanced or diffuse disease. The increase in length of
coverage appears to be associated with a concerning increase in postopera-
tive paraplegia. Female patients undergoing TEVAR should be considered
for prophylactic maneuvers to prevent SCI, including minimizing length of
coverage.
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Carotid Angioplasty and Stenting: Treatment of Post CEA Restenosis
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Objectives: To compare Transcranial Doppler (TCD) and outcome of
Carotid Angioplasty and Stenting (CAS) in post Carotid Endarterectomy
(CEA) restenoses versus primary atherosclerotic stenoses.
Design: Retrospective analysis of prospectively accumulated database.
Material and Methods: 812 CAS procedures were divided into two
groups: group 1: 72 restenoses; group 2: 740 primary stenoses. Clinical
endpoints: cerebral ischemic events and death. TCD endpoints: numbers of
isolated micro emboli and micro embolic showers, during five procedural
phases. Mann-Whitney U test and 
2-test were used. To test for indepen-
dence of variables the Mantel-Haentzel test and univariate regression anal-
ysis were performed. P.05 was regarded as statistically significant.
Results: Groups were evenly matched for demographic data (median
age: 70 vs. 71 years, male: 44/72 [61%] vs. 525/740 [71%], symptomatic
14/72 [19%] vs. 147/740 [20%]). There were 7 fatalities (0.9 %), 10 major
(1.2%) and 21 minor (2.6%) strokes, all occurred in group 2 (P0.049),
which was independent from CPD use. After correction for the difference in
CPDuse between groups (17/72 [24%] vs. 345/740 [47%]), no statistically
significant differences were found in numbers of isolated emboli and embolic
showers in any of the procedural phases, nor for the entire procedure. No
statistically significant differences were found for TCD data between early
and late restenoses analysing 2 and 3 years as cut off points.
Conclusions: CAS for restenosis after CEA has a complication rate
lower than primary CAS; time interval between CEA and CAS did not
influence micro embolic load.
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Early Commercialization Experience with New Long Term Vascular
Access for Catheter-Dependent Patients
Howard E Katzman. University of Miami Hospital, Miami, FL
Objectives: The purpose of this abstract is to report early commercial-
ization experience with the HeRO™ Vascular Access Device, a new long-
term dialysis access device approved by FDA for “access challenged” patients
i.e., catheter-dependent or patients that are poor candidates for fistulas or
grafts due to venous obstruction. TheHeRO™device is designed to provide
a graft-like vascular access and lower bacteremia rates than a tunneled dialysis
catheter.
Methods: The HeRO™ device, a graft with central outflow designed
to bypass peripheral stenosis, consists of an ePTFE upper arm graft fitted
with a titanium connector that is surgically coupled to a subcutaneous
nitinol reinforced silicone outflow catheter which exits into the right atrium
via the internal jugular vein. Procedural data has been captured on 60 early
commercialization patients implanted with the HeRO™ device including
access and medical history and device-implant success.
Results: To-date, data has been captured on 60 patients (mean age
58.9; 43.3% male; 55.0% diabetic) with a history of 4.1 years on dialysis, a
mean 5.0 previous catheters, 2.2 previous grafts, and 1.5 previous fistulas
and 3.6 mean previous bacteremias (range 1-17). The HeRO™ device was
successfully implanted in all subjects using a variety of interventional tech-
niques, although 60.0% percent had evidence of hemodynamically signifi-
cant central venous stenosis.
Conclusions: This data demonstrates that access-challenged patients
with challenging anatomy and central venous stenosis may be eligible for an
alternative long-term vascular access device offering lower bacteremia rates
compared to a tunneled dialysis catheter.
Author Disclosures: H.E. Katzman, Participating in HeRO commercial-
ization registry on behalf of Hemosphere, Inc and receiving nominal re-
search grant to complete case report forms as investigator in registry.
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Reduction and Reconstruction of Aneurysmal Arteriovenous Fistulas:
Mid-Term Results of a Novel Approach to Salvage Autogenous Dialysis
Access
Karen Woo1, Patrick R Cook1, Robert J Hye2, Timothy G Canty2. 1Scripps
Green Hospital, La Jolla, CA; 2Kaiser Permanente Medical Group, San
Diego, CA
Background: Over the last decade, K-DOQI guidelines have increas-
ingly emphasized the importance of autogenous arteriovenous fistulas
(AVF) for dialysis access. A complication of AVF is aneurysmal dilatation
with a subset developing massive diffuse aneurysm. Treatment of massive
aneurysmal AVF generally involves either ligation or resection with use of
prosthetic interposition. In order to maintain an all-autogenous access, we
developed a procedure to treat massive aneurysmal AVF in which the
lumenal diameter is reduced, excess length is resected, and the new recon-
structed AVF is retunneled for continued use.
Methods: Over a 4-year period, the reduction/revision procedure was
performed on 18 patients with an AVF diameter of 4-7cm. Indications for
operation were thrombosis, skin breakdown, infection, bleeding, and/or
poor flow. Revision was performed by resecting redundant length, reducing
diameter, and then reconstructing the fistula.
Results: Patients ranged in age from 25 to 83 with a mean of 48. There
were 12 men and 6 women. The mean and median follow-up was 20
months. The mean and median primary patency was 17 and 14 months,
respectively. The mean and median secondary patency was 19 and 16.5
months, respectively. Two patients died, one AVF thrombosed, and two
were ligated secondary to infection. One fistula developed a stenosis that was
treated with angioplasty. There are no recurrent aneurysms to date.
Conclusions: Surgical resection of excess length, reduction of lumenal
diameter, and reconstruction is a viable option for the treatment of compli-
cated massive diffusely aneurysmal AVF. This technique offers the ability to
maintain the benefits of an all autogenous dialysis access while conserving
future dialysis sites.Author Disclosures: K. Woo, None; P.R. Cook, None; R.J. Hye, None;
T.G. Canty, None.
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Background: As Vascular surgery training has evolved from a single
clinical year following general surgery training to a multi year training
program with independent certification, the need for an in-training exami-
nation to assess the preparedness of the candidate for the certification
process has become apparent. Our objective is to analyze the psychometric
characteristics of the first Vascular Surgery In-Training Examination
(VSITE) and to correlate performance on the VSITE with performance on
the Qualifying Examination (QE) in Vascular Surgery.
Methods: The Vascular Surgery Board (VSB) in conjunction with the
Association of ProgramDirectors in Vascular Surgery (APDVS) appointed a
panel to develop the VSITE which was administered by the Vascular Surgery
Board of the American Board of Surgery(VSB/ABS). Thirty-one APDVS
and SVSmembers contributed questions in clinical and basic science areas of
vascular surgery training. All questions were again reviewed by the panel and
the VSB/ABS prior to administration of the examination. The psychometric
characteristics of the examination and correlation of performance on VSITE
and VQE were undertaken by ABS staff.
Results: On February 16, 2008, 240 examinees took the initial Vascu-
lar Surgery In-Training Examination online through a secure, proctored
website. This total included 216 vascular residents from 91 of 95 (96%)
training programs. The psychometric properties of the examination were
excellent with index values comparable to other ABS examinations. The
average difficulty value for all items was 76.6%, the average discrimination
value was 0.20, the total test reliability coefficient was 0.85 and the standard
error of measurement was 2.9% correct. Scores ranged from 55% to 93%
correct with an average of 76.7% correct. Sixty-four candidates took both the
VSITE and the VQE in 2008. A high correlation of 0.70 was noted between
